1. Li C, Sheng S, Men Y, Sun H, Xia H, Li L. Emission computed tomography for the diagnosis of mandibular invasion by head and neck cancers: a systematic review and meta-analysis. J Oral Maxillofac Surg. 2015;73(9):1875.e1–11. Epub May 11.
2. Hayashi K, Kikuchi M, Imai Y, Yamashita D, Hino M, Ito K, et al. Clinical value of fused PET/MRI for surgical planning in patients with oral/oropharyngeal carcinoma. Laryngoscope. 2019;21(10):27,911.
3. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49(3):480–508. https://doi.org/10.2967/jnumed.107.047787. Epub 2008 Feb 20.
4. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008;100(10):712–20. https://doi.org/10.1093/jnci/djn125. Epub 2008 May 13.
5. Schoder H, Carlson DL, Kraus DH, Stambuk HE, Gonen M, Erdi YE, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med. 2006;47(5):755–62.